Next Gen Diagnostics Appoints Karlyn Dauplaise as Chief Commercial Officer of NGD Infection Prevention
Position
Chief Commercial Officer
Company
NGD Infection Prevention
CambridgeBiotechnologyHealth CareGeneticsHealth DiagnosticsDescription
Next Gen Diagnostics has announced the appointment of Karlyn Dauplaise as the Chief Commercial Officer of its new division, NGD Infection Prevention. She will lead the company's commercial strategy and customer partnerships to enhance infection detection and prevention in hospitals.
Quick answer
Next Gen Diagnostics Appoints Karlyn Dauplaise as Chief Commercial Officer of NGD Infection Prevention (January 5, 2026). NGD Infection Prevention is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Commercial Officer at NGD Infection Prevention?
- NGD Infection Prevention named Karlyn Dauplaise Chief Commercial Officer, announced January 5, 2026.
- What did NGD Infection Prevention announce on January 5, 2026?
- Next Gen Diagnostics has announced the appointment of Karlyn Dauplaise as the Chief Commercial Officer of its new division, NGD Infection Prevention. She will lead the company's commercial strategy and customer partnerships to enhance infection detection and prevention in hospitals.
- What does NGD Infection Prevention do?
- NGD Infection Prevention delivers automated whole-genome sequencing and real-time transmission detection to help hospitals reduce preventable infections, improve patient safety, and optimize operational and financial...
- Where is NGD Infection Prevention based?
- NGD Infection Prevention is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- RetinalGeniX Technologies (December 9, 2025), BioMarin Pharmaceutical (January 12, 2026), Proteomics International (January 18, 2026) and Thyrocare Technologies (December 18, 2025) also announced leadership changes within 45 days of NGD Infection Prevention.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Health Diagnostics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- RetinalGenix Technologies Inc. Appoints M. Cory Zwerling as Interim Chief Operating Officer (December 9, 2025)
- BioMarin Appoints Arpit Davé as Chief Digital and Information Officer (January 12, 2026)
- Proteomics International Appoints David Morris as Chief Executive Officer (January 18, 2026)
- Thyrocare Technologies Appoints Dr Ramesh Kinha as Chief Operating Officer (December 18, 2025)
- Cleveland Diagnostics Appoints Michael Iskra as Chief Executive Officer (January 26, 2026)
- REVEAL GENOMICS Appoints Joel Parker as Chief Scientific Officer (January 27, 2026)
Who to call at NGD Infection Prevention, and when
A new leader at NGD Infection Prevention brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day NGD Infection Prevention raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NGD Infection Prevention, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NGD Infection Prevention. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NGD Infection Prevention changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
NGD Infection Prevention changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.